Volume | 778 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Enlivex Therapeutics Ltd | ENLV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.61 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
17 | 778 | - | 1.15 - 4.59 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
07:27:57 | 20 | US$ 1.60 | USD |
Enlivex Therapeutics Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
29.66M | 18.42M | - | 0 | -31.06M | -1.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Enlivex Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENLV Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.4502 | 1.84 | 1.44 | 1.63 | 153,123 | 0.1998 | 13.78% |
1 Month | 4.06 | 4.43 | 1.15 | 1.86 | 366,851 | -2.41 | -59.36% |
3 Months | 2.64 | 4.59 | 1.15 | 2.44 | 187,571 | -0.99 | -37.50% |
6 Months | 1.35 | 4.59 | 1.15 | 2.52 | 134,459 | 0.30 | 22.22% |
1 Year | 2.885 | 4.59 | 1.15 | 2.47 | 78,751 | -1.24 | -42.81% |
3 Years | 12.17 | 13.95 | 1.15 | 6.66 | 86,120 | -10.52 | -86.44% |
5 Years | 11.10 | 44.90 | 1.15 | 9.83 | 162,674 | -9.45 | -85.14% |
Enlivex Therapeutics Description
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. |